395 related articles for article (PubMed ID: 26071989)
1. The use of cannabinoids as anticancer agents.
Velasco G; Hernández-Tiedra S; Dávila D; Lorente M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():259-66. PubMed ID: 26071989
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids and Cancer.
Velasco G; Sánchez C; Guzmán M
Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids as Anticancer Drugs.
Ramer R; Hinz B
Adv Pharmacol; 2017; 80():397-436. PubMed ID: 28826542
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid-associated cell death mechanisms in tumor models (review).
Calvaruso G; Pellerito O; Notaro A; Giuliano M
Int J Oncol; 2012 Aug; 41(2):407-13. PubMed ID: 22614735
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.
Boyacıoğlu Ö; Korkusuz P
Adv Exp Med Biol; 2023; 1410():145-169. PubMed ID: 36396926
[TBL] [Abstract][Full Text] [Related]
8. Antitumorigenic targets of cannabinoids - current status and implications.
Ramer R; Hinz B
Expert Opin Ther Targets; 2016 Oct; 20(10):1219-35. PubMed ID: 27070944
[TBL] [Abstract][Full Text] [Related]
9. The Endocannabinoid System: A Target for Cancer Treatment.
Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour actions of cannabinoids.
Hinz B; Ramer R
Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
[TBL] [Abstract][Full Text] [Related]
11. A Review of the Therapeutic Antitumor Potential of Cannabinoids.
Bogdanović V; Mrdjanović J; Borišev I
J Altern Complement Med; 2017 Nov; 23(11):831-836. PubMed ID: 28799775
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?
Pushkarev VM; Kovzun OI; Tronko MD
Exp Oncol; 2008 Mar; 30(1):6-21. PubMed ID: 18438336
[TBL] [Abstract][Full Text] [Related]
13. Antitumorigenic effects of cannabinoids beyond apoptosis.
Freimuth N; Ramer R; Hinz B
J Pharmacol Exp Ther; 2010 Feb; 332(2):336-44. PubMed ID: 19889794
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids: potential anticancer agents.
Guzmán M
Nat Rev Cancer; 2003 Oct; 3(10):745-55. PubMed ID: 14570037
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanism of Cannabinoids in Cancer Progression.
Pagano C; Navarra G; Coppola L; Bifulco M; Laezza C
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916164
[TBL] [Abstract][Full Text] [Related]
16. Targeting the endocannabinoid system for the treatment of cancer--a practical view.
Fowler CJ; Gustafsson SB; Chung SC; Persson E; Jacobsson SO; Bergh A
Curr Top Med Chem; 2010; 10(8):814-27. PubMed ID: 20370711
[TBL] [Abstract][Full Text] [Related]
17. Insights into the effects of the endocannabinoid system in cancer: a review.
Fraguas-Sánchez AI; Martín-Sabroso C; Torres-Suárez AI
Br J Pharmacol; 2018 Jul; 175(13):2566-2580. PubMed ID: 29663308
[TBL] [Abstract][Full Text] [Related]
18. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids as Guardians of Metastasis.
Tegeder I
Int J Mol Sci; 2016 Feb; 17(2):230. PubMed ID: 26875980
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids as anticancer drugs: current status of preclinical research.
Hinz B; Ramer R
Br J Cancer; 2022 Jul; 127(1):1-13. PubMed ID: 35277658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
